Offer - Urjas Oil for just ₹ 1 X
D.D.Pramine 25 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Obsessive Compulsive Disorder.
The right dosage of D.D.Pramine 25 Mg Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Some other side effects of D.D.Pramine 25 Mg Tablet have been listed ahead. Usually, these side effects of D.D.Pramine 25 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
D.D.Pramine 25 Mg Tablet's effect during pregnancy is Moderate and Severe while nursing. In addition, D.D.Pramine 25 Mg Tablet's effects on the liver, heart and kidney are discussed below in the D.D.Pramine 25 Mg Tablet related warnings section.
Individuals suffering from medical conditions like Heart Disease, Coronary Artery Disease (CAD), Suicidal Tendency must refrain from the use of D.D.Pramine 25 Mg Tablet since this can cause severe adverse effects. Other contraindications of D.D.Pramine 25 Mg Tablet have been discussed in the sections ahead.
Drug interactions for D.D.Pramine 25 Mg Tablet have been reported in the medical literature. See below for a complete list.
You should also be aware that D.D.Pramine 25 Mg Tablet is not safe while driving, and is not addiction.
D.D.Pramine 25 Mg Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of D.D.Pramine 25 Mg Tablet safe for pregnant women?
D D Pramine can have harmful effects in pregnant women. If you experience any discomfort after using D D Pramine, then discontinue the use and take your doctor's advice.
Is the use of D.D.Pramine 25 Mg Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking D D Pramine. It should only be taken after medical advice.
What is the effect of D.D.Pramine 25 Mg Tablet on the Kidneys?
D D Pramine is completely safe for kidneys.
What is the effect of D.D.Pramine 25 Mg Tablet on the Liver?
Side effects of D D Pramine rarely affect the liver.
What is the effect of D.D.Pramine 25 Mg Tablet on the Heart?
D D Pramine has very mild side effects on the heart.
D.D.Pramine 25 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take D.D.Pramine 25 Mg Tablet unless your doctor advises you to do so -
Is this D.D.Pramine 25 Mg Tablet habit forming or addictive?
D.D.Pramine 25 Mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking D.D.Pramine 25 Mg Tablet as you may feel sleepy.
Is it safe?
Yes, but consume D.D.Pramine 25 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
Yes, D.D.Pramine 25 Mg Tablet is useful in treating mental disorders.
Interaction between Food and D.D.Pramine 25 Mg Tablet
You can take D.D.Pramine 25 Mg Tablet with food.
Interaction between Alcohol and D.D.Pramine 25 Mg Tablet
Consult your doctor before consuming alcohol while taking D.D.Pramine 25 Mg Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Anafranil® (clomipramine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 454, 456, 458, 464